Blyth is the founder and former CEO of LIfT BioSciences, a company developing neutrophil-based immunotherapies designed to ...
PITTSBURGH, PA, UNITED STATES, February 27, 2026 /EINPresswire.com/ -- Tamara K. of Deer Lodge, TN is the creator of ...
A discussion of the current landscape of generative AI (GenAI) patent drafting tools, including the differences between fully ...
Medical Xpress on MSN
'Dancing molecules' paralysis treatment heals lab-grown human spinal cord organoids
Northwestern University scientists have developed the most advanced organoid model for human spinal cord injury to date. In a new study, the research team used lab-grown human spinal cord ...
How did the United States overtake Europe to become the world's technological leader within just a few decades? A new study by researcher Frank Neffke from the Complexity Science Hub (CSH) and ...
When Katharine Burr Blodgett discovered nonreflecting glass, the General Electric Company’s public relations machine made her a star ...
Gemma Biotherapeutics ("GEMMABio"), a clinical?stage global genetic medicines company, announced today that the first patient has been dosed in the Phase 1/2 CHARISMA clinical trial of GB221, an ...
Researchers identified a molecular pathway that can limit muscle repair, a finding that may guide future muscular dystrophy treatments.
Blood vessel damage in the spinal cord may play a role in nerve cell loss in spinal muscular atrophy, a new study suggests.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results